Intended for healthcare professionals

Rapid response to:

Research News

Risk of breast cancer recurrence remains for years after endocrine treatment ends, study finds

BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j5167 (Published 08 November 2017) Cite this as: BMJ 2017;359:j5167

Rapid Response:

Reply to Psychiatrist Eugene G Breen

Longer follow up always proves oral contraceptives beneficial.
Recent evidence from long term observations of hundreds of thousands of women, in 10 European Countries, clearly demonstrated that the use of oral contraceptives reduced mortality by roughly 10%. [1][3]
Newer oral contraceptives increase womens' overall survival.
In comparison, drastically reducing obesity by 5 BMI points would only reduce mortality by 5%, from 1.05 to 1. [2]
Your excellent prose cannot beat hard clinical evidence in this argument.

References
[1] doi: 10.1186/s12916-015-0484-3.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627614/
[2] http://www.bmj.com/content/353/bmj.i2156
[3] https://www.ncbi.nlm.nih.gov/pubmed/28188769

Competing interests: No competing interests

09 November 2017
Stavros Saripanidis
Consultant in Obstetrics and Gynaecology
Thessaloniki, Hellas